201 related articles for article (PubMed ID: 24811334)
1. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
[TBL] [Abstract][Full Text] [Related]
2. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.
Freeman JB; Gray ES; Millward M; Pearce R; Ziman M
J Transl Med; 2012 Sep; 10():192. PubMed ID: 22978632
[TBL] [Abstract][Full Text] [Related]
5. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
[TBL] [Abstract][Full Text] [Related]
6. Magnetic bead RT-PCR: establishment of a new method for detecting circulating melanoma cells.
Georgieva J; Milling A; Orfanos CE; Geilen CC
Melanoma Res; 2002 Aug; 12(4):309-17. PubMed ID: 12170179
[TBL] [Abstract][Full Text] [Related]
7. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
8. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
9. [Detection of circulating malignant cells in patients with uveal melanoma].
Fernandes BF; Antecka E; dos Passos G; Burnier MN
Arq Bras Oftalmol; 2007; 70(4):593-8. PubMed ID: 17906753
[TBL] [Abstract][Full Text] [Related]
10. Immunomagnetic enrichment, genomic characterization, and prognostic impact of circulating melanoma cells.
Ulmer A; Schmidt-Kittler O; Fischer J; Ellwanger U; Rassner G; Riethmüller G; Fierlbeck G; Klein CA
Clin Cancer Res; 2004 Jan; 10(2):531-7. PubMed ID: 14760074
[TBL] [Abstract][Full Text] [Related]
11. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
12. Multi-Marker Immunomagnetic Enrichment of Circulating Melanoma Cells.
Beasley AB; Acheampong E; Lin W; Gray ES
Methods Mol Biol; 2021; 2265():213-222. PubMed ID: 33704717
[TBL] [Abstract][Full Text] [Related]
13. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS
Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581
[TBL] [Abstract][Full Text] [Related]
14. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
[TBL] [Abstract][Full Text] [Related]
15. Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology.
Wu Y; Deighan CJ; Miller BL; Balasubramanian P; Lustberg MB; Zborowski M; Chalmers JJ
Methods; 2013 Dec; 64(2):169-82. PubMed ID: 24056212
[TBL] [Abstract][Full Text] [Related]
16. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.
Chen Q; Yao L; Burner D; Minev B; Lu L; Wang M; Ma W
Clin Transl Oncol; 2019 Apr; 21(4):433-442. PubMed ID: 30218306
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.
Cools-Lartigue JJ; McCauley CS; Marshall JC; Di Cesare S; Gregoire F; Antecka E; Logan P; Burnier MN
Mol Vis; 2008 Jan; 14():50-5. PubMed ID: 18246031
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.
Kitago M; Koyanagi K; Nakamura T; Goto Y; Faries M; O'Day SJ; Morton DL; Ferrone S; Hoon DS
Clin Chem; 2009 Apr; 55(4):757-64. PubMed ID: 19233913
[TBL] [Abstract][Full Text] [Related]
20. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]